The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa

This publication has 14 references indexed in Scilit:

• A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas
  Tubercle, 1969
• Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa—Fourth investigation: The effect of increasing the dosage of isoniazid
  Tubercle, 1966
• A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus pas
  Tubercle, 1966
• Isoniazid with thiacetazone (Thioacetazone) in the treatment of pulmonary tuberculosis in East Africa—third investigation: The effect of an initial streptomycin supplement: A co-operative study in East African hospitals and laboratories with the collaboration of the East African and British medical research councils
  Tubercle, 1966
• Cost-Benefit Analysis: A Survey
  The Economic Journal, 1965
• Realistic Chemotherapeutic Policies for Tuberculosis in the Developing Countries
  BMJ, 1964
• Acquired drug-resistance in patients with pulmonary tuberculosis in Great Britain—A national survey, 1960–61: A Report from the Research Committee of the British Tuberculosis Association
  Tubercle, 1963
• The initiation of chemotherapy in pulmonary tuberculosis in West Africans Hospital and ambulant treatment compared using streptomycyclidine-isonicotinic acid hydrazide
  Respiratory Medicine, 1960
• RECENT DEVELOPMENTS IN CONTROLLED TRIALS IN PULMONARY TUBERCULOSIS
  British Medical Bulletin, 1954
• Chemotherapy of Pulmonary Tuberculosis in Young Adults
  BMJ, 1952